Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

NCT00674024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Neoplasms
Lymphoma

Interventions

DRUG: Pazopanib
DRUG: Pazopanib (GW786034)(GW786034)

Sponsor

National Cancer Institute (NCI)